-
1.发明公开公开(公告)号：US20240269162A1
公开(公告)日：2024-08-15
申请号：US18445785
申请日：2024-02-01
申请人： Kedar Prasad
发明人： Kedar Prasad
IPC分类号： A61K31/714 , A61K31/197 , A61K31/355 , A61K31/375 , A61K31/4188 , A61K31/4415 , A61K31/455 , A61K31/51 , A61K31/525 , A61K33/04 , A61K33/06 , A61K33/30 , A61P39/00
CPC分类号： A61K31/714 , A61K31/197 , A61K31/355 , A61K31/375 , A61K31/4188 , A61K31/4415 , A61K31/455 , A61K31/51 , A61K31/525 , A61K33/04 , A61K33/06 , A61K33/30 , A61P39/00
摘要： A formulation comprising at least one vitamin, at least one antioxidant, at least one mineral, at least one plant based nutrient and sodium.
-
公开(公告)号：US12016950B2
公开(公告)日：2024-06-25
申请号：US17379804
申请日：2021-07-19
申请人： Try This First, Inc.
发明人： Scott Morehouse
IPC分类号： A61K31/355 , A23G3/56 , A61B17/24 , A61K9/00 , A61K31/045 , A61K31/047 , A61K31/07 , A61K31/167 , A61K31/19 , A61K31/192 , A61K31/194 , A61K31/197 , A61K31/375 , A61K31/4188 , A61K31/4415 , A61K31/455 , A61K31/51 , A61K31/519 , A61K31/525 , A61K31/616 , A61K31/675 , A61K31/7032 , A61K33/00 , A61K33/06 , A61K36/00 , A61K36/28 , A61K36/48 , A61K36/534 , A61K36/63 , A61K36/71 , A61K36/752 , A61K36/808 , A61K45/06
CPC分类号： A61K9/0056 , A23G3/563 , A61B17/24 , A61K31/045 , A61K31/047 , A61K31/07 , A61K31/167 , A61K31/19 , A61K31/192 , A61K31/194 , A61K31/197 , A61K31/355 , A61K31/375 , A61K31/4188 , A61K31/4415 , A61K31/455 , A61K31/51 , A61K31/519 , A61K31/525 , A61K31/616 , A61K31/675 , A61K31/7032 , A61K33/00 , A61K33/06 , A61K36/00 , A61K36/28 , A61K36/48 , A61K36/534 , A61K36/63 , A61K36/71 , A61K36/752 , A61K36/808 , A61K45/06
摘要： The present invention relates generally to a methods and apparatuses for treating ear pain and clearing excess fluid from Eustachian tubes.
-
公开(公告)号：US20240181059A1
公开(公告)日：2024-06-06
申请号：US18418822
申请日：2024-01-22
申请人： Next2Me, LLC
IPC分类号： A61K41/00 , A61K31/197 , A61K31/4188 , A61K31/4415 , A61K31/455 , A61K31/51 , A61K31/519 , A61K31/525 , A61K31/661 , A61K31/714 , A61K36/06 , A61K36/23 , A61K36/68 , A61K36/9068
CPC分类号： A61K41/0004 , A61K31/197 , A61K31/4188 , A61K31/4415 , A61K31/455 , A61K31/51 , A61K31/519 , A61K31/525 , A61K31/661 , A61K31/714 , A61K36/06 , A61K36/23 , A61K36/68 , A61K36/9068
摘要： Biochemical scaffolds for treating menopausal symptoms. The biochemical scaffolds include a base liquid medium, a bioenergetic platform and a vibrational platform. The bioenergetic platform includes at least one Krebs cycle modulator and/or neurotransmitter modulator and/or nuclear hormone receptor modulator. The vibrational platform includes at least one energy signature component, e.g., an herb. The biochemical scaffold is subjected to sequential harmonic oscillation for a defined, predetermined period of time, wherein the energy signature of the energy signature component is imparted to, captured, replicated, and retained by the liquid medium, and, when the biochemical scaffolds are delivered to and, thus, in communication with biological tissue, the biochemical scaffolds induce specific biochemical activities via the resonant transfer of the retained energy signature to the biological tissue and, hence, endogenous cells thereof.
-
公开(公告)号：US20240158359A1
公开(公告)日：2024-05-16
申请号：US18498933
申请日：2023-10-31
IPC分类号： C07D277/10 , A61K31/40 , A61K31/525 , A61P31/00
CPC分类号： C07D277/10 , A61K31/40 , A61K31/525 , A61P31/00
摘要： A novel carboxylate luciferin substrate or methotrexate compound is disclosed as having at least one substituted benzyl ester group masking a carboxyl group. The substituted benzyl ester group may have a stabilizing substitution on the benzylic position. The stabilizing substitution on the benzylic position may be a methyl, phenyl group or a branched C3-C5 alkyl group. The luciferin substrate may provide an imaging agent or ABS may have NIR BL activity. Optionally, there is a trigger group at the para position or ortho position, or optionally both.
-
公开(公告)号：US20240131161A1
公开(公告)日：2024-04-25
申请号：US18400485
申请日：2023-12-29
申请人： Next2Me, LLC
发明人： Ralph L Peterson , Renee D Williman
IPC分类号： A61K41/00 , A61K31/197 , A61K31/4188 , A61K31/4415 , A61K31/455 , A61K31/51 , A61K31/519 , A61K31/525 , A61K31/661 , A61K31/714 , A61K36/06 , A61K36/23 , A61K36/68 , A61K36/9068
CPC分类号： A61K41/0004 , A61K31/197 , A61K31/4188 , A61K31/4415 , A61K31/455 , A61K31/51 , A61K31/519 , A61K31/525 , A61K31/661 , A61K31/714 , A61K36/06 , A61K36/23 , A61K36/68 , A61K36/9068
摘要： Biochemical scaffolds for regulating mammalian cell function. The biochemical scaffolds include a base liquid medium, a bioenergetic platform and a vibrational platform. The bioenergetic platform includes at least one Krebs cycle modulator and/or neurotransmitter modulator. The vibrational platform includes at least one energy signature component, e.g., an herb. The biochemical scaffold is subjected to harmonic oscillation for a defined, predetermined period of time, wherein the energy signature of the energy signature component is imparted to, captured, replicated, and retained by the liquid medium, and, when the biochemical scaffolds are delivered to and, thus, in communication with biological tissue, the biochemical scaffolds induce specific biochemical activities via the resonant transfer of the retained energy signature to the biological tissue and, hence, endogenous cells thereof.
-
公开(公告)号：US20240131091A1
公开(公告)日：2024-04-25
申请号：US18477298
申请日：2023-09-27
申请人： Solarea Bio, Inc.
发明人： Eric Michael Schott , Gerardo V. Toledo , Maria Juliana Soto-Giron , Alicia Eve Ballok , Ryan Green , Mark Charbonneau
IPC分类号： A61K35/747 , A23L33/105 , A23L33/135 , A23L33/15 , A61K31/525 , A61K35/742 , A61K45/06 , A61P29/00
CPC分类号： A61K35/747 , A23L33/105 , A23L33/135 , A23L33/15 , A61K31/525 , A61K35/742 , A61K45/06 , A61P29/00
摘要： This disclosure provides for compositions (e.g., pharmaceutical compositions, dietary supplements, medical foods and food stuff), comprising combinations of live microbe populations for the treatment and/or prevention of immune system disorders and conditions related to inflammation, including both pathogen assisted conditions and conditions that are independent of pathogens. Included with the present disclosure are methods for use of the compositions, and methods for selecting microbial entities to formulate the compositions of the disclosure.
-
公开(公告)号：US11963992B2
公开(公告)日：2024-04-23
申请号：US17379255
申请日：2021-07-19
发明人： Per-Arne Öckerman
IPC分类号： A61K31/07 , A23L33/105 , A23L33/115 , A23L33/135 , A23L33/15 , A23L33/155 , A23L33/16 , A23L33/175 , A61K31/01 , A61K31/015 , A61K31/122 , A61K31/14 , A61K31/197 , A61K31/198 , A61K31/355 , A61K31/375 , A61K31/4188 , A61K31/4415 , A61K31/455 , A61K31/51 , A61K31/519 , A61K31/525 , A61K31/59 , A61K31/593 , A61K31/7004 , A61K31/714 , A61K33/06 , A61K33/14 , A61K33/18 , A61K33/24 , A61K33/30 , A61K33/32 , A61K33/34 , A61K33/42 , A61K35/60 , A61K35/744 , A61K35/747 , A61K36/45 , A61K36/752
CPC分类号： A61K36/752 , A23L33/105 , A23L33/115 , A23L33/135 , A23L33/15 , A23L33/155 , A23L33/16 , A23L33/175 , A61K31/01 , A61K31/015 , A61K31/07 , A61K31/122 , A61K31/14 , A61K31/197 , A61K31/198 , A61K31/355 , A61K31/375 , A61K31/4188 , A61K31/4415 , A61K31/455 , A61K31/51 , A61K31/519 , A61K31/525 , A61K31/59 , A61K31/593 , A61K31/7004 , A61K31/714 , A61K33/06 , A61K33/14 , A61K33/18 , A61K33/24 , A61K33/30 , A61K33/32 , A61K33/34 , A61K33/42 , A61K35/60 , A61K35/744 , A61K35/747 , A61K36/45 , A23V2002/00 , A61K35/60 , A61K2300/00 , A61K36/752 , A61K2300/00 , A61K35/744 , A61K2300/00 , A61K35/747 , A61K2300/00 , A61K36/45 , A61K2300/00 , A61K31/07 , A61K2300/00 , A61K31/01 , A61K2300/00 , A61K31/122 , A61K2300/00 , A61K31/14 , A61K2300/00 , A61K31/197 , A61K2300/00 , A61K31/198 , A61K2300/00 , A61K31/355 , A61K2300/00 , A61K31/375 , A61K2300/00 , A61K31/4188 , A61K2300/00 , A61K31/4415 , A61K2300/00 , A61K31/455 , A61K2300/00 , A61K31/51 , A61K2300/00 , A61K31/519 , A61K2300/00 , A61K31/525 , A61K2300/00 , A61K31/593 , A61K2300/00 , A61K31/7004 , A61K2300/00 , A61K31/714 , A61K2300/00 , A61K31/59 , A61K2300/00 , A61K31/015 , A61K2300/00 , A61K33/06 , A61K2300/00 , A61K33/18 , A61K2300/00 , A61K33/24 , A61K2300/00 , A61K33/42 , A61K2300/00 , A61K33/14 , A61K2300/00 , A61K33/34 , A61K2300/00 , A61K33/30 , A61K2300/00 , A61K33/32 , A61K2300/00 , A23V2002/00 , A23V2200/3204 , A23V2200/326 , A23V2250/06 , A23V2250/156 , A23V2250/1882 , A23V2250/211 , A23V2250/2116 , A23V2250/702 , A23V2250/704 , A23V2250/708 , A23V2250/71 , A23V2250/712 , A23V2250/714
摘要： Various embodiments of the invention relate to compositions comprising vitamins, minerals and trace elements, antioxidants, amino acids, probiotics, and other components and methods for using such compositions to treat or prevent diseases associated with oxidative stress, including cardiovascular disease.
-
公开(公告)号：US11938152B2
公开(公告)日：2024-03-26
申请号：US16987008
申请日：2020-08-06
申请人： Kedar N Prasad
发明人： Kedar N Prasad
IPC分类号： A61K33/30 , A61K9/00 , A61K31/05 , A61K31/07 , A61K31/12 , A61K31/122 , A61K31/197 , A61K31/198 , A61K31/352 , A61K31/355 , A61K31/375 , A61K31/385 , A61K31/4415 , A61K31/455 , A61K31/51 , A61K31/519 , A61K31/525 , A61K31/593 , A61K31/714 , A61P35/00
CPC分类号： A61K33/30 , A61K9/0095 , A61K31/05 , A61K31/07 , A61K31/12 , A61K31/122 , A61K31/197 , A61K31/198 , A61K31/352 , A61K31/355 , A61K31/375 , A61K31/385 , A61K31/4415 , A61K31/455 , A61K31/51 , A61K31/519 , A61K31/525 , A61K31/593 , A61K31/714 , A61P35/00
摘要： This invention proposes that a mixture of high doses of multiple antioxidants in combination with therapeutic agents may improve the management of cancer without toxicity.
-
公开(公告)号：US20240082197A1
公开(公告)日：2024-03-14
申请号：US18369616
申请日：2023-09-18
发明人： Thuong Cao Do , Ping Yang
IPC分类号： A61K31/202 , A23L33/105 , A23L33/12 , A23L33/125 , A23L33/14 , A23L33/155 , A23L33/16 , A61K9/00 , A61K9/48 , A61K9/50 , A61K31/047 , A61K31/07 , A61K31/197 , A61K31/355 , A61K31/375 , A61K31/4188 , A61K31/4415 , A61K31/455 , A61K31/51 , A61K31/519 , A61K31/525 , A61K31/593 , A61K31/685 , A61K31/714 , A61K33/00 , A61K33/08 , A61K33/18 , A61K33/26 , A61K33/30 , A61K35/60 , A61K36/064 , A61K36/28
CPC分类号： A61K31/202 , A23L33/105 , A23L33/12 , A23L33/125 , A23L33/14 , A23L33/155 , A23L33/16 , A61K9/0053 , A61K9/4858 , A61K9/50 , A61K31/047 , A61K31/07 , A61K31/197 , A61K31/355 , A61K31/375 , A61K31/4188 , A61K31/4415 , A61K31/455 , A61K31/51 , A61K31/519 , A61K31/525 , A61K31/593 , A61K31/685 , A61K31/714 , A61K33/00 , A61K33/08 , A61K33/18 , A61K33/26 , A61K33/30 , A61K35/60 , A61K36/064 , A61K36/28 , A23V2002/00
摘要： The present invention relates to the delivery method of Omega-3's and nutritional supplements for the human diet used to aid mental and visual development of human embryos as well as enhance visual acuity and mental fitness in humans. The invention contains vitamins, minerals, and microencapsulated fish oil powder containing DHA and EPA.
-
公开(公告)号：US20240000879A1
公开(公告)日：2024-01-04
申请号：US18466461
申请日：2023-09-13
申请人： Spoke Sciences, Inc.
发明人： Andrea Leone-Bay , Gregory Wesner
IPC分类号： A61K36/752 , A23L33/17 , A23L33/105 , A23L33/15 , A61K31/07 , A61K31/122 , A61K31/20 , A61K31/355 , A61K31/375 , A61K31/4415 , A61K31/51 , A61K31/525 , A61K31/59 , A61K31/714 , A61K33/06 , A61K33/18 , A61K33/26 , A61K33/30 , A61K36/36 , A61K36/51 , A61K36/53 , A61K36/61 , A61K36/81 , A61K36/9066
CPC分类号： A61K36/752 , A23L33/17 , A23L33/105 , A23L33/15 , A61K31/07 , A61K31/122 , A61K31/20 , A61K31/355 , A61K31/375 , A61K31/4415 , A61K31/51 , A61K31/525 , A61K31/59 , A61K31/714 , A61K33/06 , A61K33/18 , A61K33/26 , A61K33/30 , A61K36/36 , A61K36/51 , A61K36/53 , A61K36/61 , A61K36/81 , A61K36/9066 , A61K9/0056
摘要： Herbal compositions in various carrier combinations are described. The carriers can include N-acylated fatty amino acids, penetration enhancers, and/or various other beneficial carriers. The herbal composition/carrier combinations can create administration benefits.
-
-
-
-
-
-
-
-
-
搜索结果
1465 条记录 (耗时 0.028 秒)
